{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T23:32:06Z","timestamp":1778110326243,"version":"3.51.4"},"reference-count":164,"publisher":"Elsevier","isbn-type":[{"value":"9780323901642","type":"print"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/bs.pbr.2022.01.014","type":"book-chapter","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T09:49:42Z","timestamp":1644572982000},"page":"177-193","source":"Crossref","is-referenced-by-count":6,"title":["Neuropathological substrates of cognition in Parkinson's disease"],"prefix":"10.1016","member":"78","reference":[{"issue":"5","key":"10.1016\/bs.pbr.2022.01.014_bb0010","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/ana.20635","article-title":"Neuropathology of dementia in Parkinson's disease: a prospective, community-based study","volume":"58","author":"Aarsland","year":"2005","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/bs.pbr.2022.01.014_bb0015","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1523\/JNEUROSCI.3047-16.2016","article-title":"Hippocampal alpha-synuclein in dementia with Lewy bodies contributes to memory impairment and is consistent with spread of pathology","volume":"37","author":"Adamowicz","year":"2017","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/bs.pbr.2022.01.014_bb0020","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1212\/WNL.0000000000000641","article-title":"Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study","volume":"83","author":"Adler","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/bs.pbr.2022.01.014_bb0025","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/jnen\/nlz080","article-title":"Unified staging system for Lewy body disorders: clinicopathologic correlations and comparison to Braak staging","volume":"78","author":"Adler","year":"2019","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"2\u20133","key":"10.1016\/bs.pbr.2022.01.014_bb0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.baga.2015.06.001","article-title":"The vulnerable ventral tegmental area in Parkinson's disease","volume":"5","author":"Alberico","year":"2015","journal-title":"Basal ganglia"},{"issue":"10","key":"10.1016\/bs.pbr.2022.01.014_bb0035","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1136\/jnnp.2009.199950","article-title":"CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study","volume":"81","author":"Alves","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/bs.pbr.2022.01.014_bb0040","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1001\/archneur.59.1.102","article-title":"Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response","volume":"59","author":"Apaydin","year":"2002","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/bs.pbr.2022.01.014_bb0045","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neuron.2019.10.010","article-title":"Amyloid-Beta (A\u03b2) plaques promote seeding and spreading of alpha-synuclein and tau in a mouse model of Lewy body disorders with A\u03b2 pathology","volume":"105","author":"Bassil","year":"2020","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/bs.pbr.2022.01.014_bb0050","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20192193","article-title":"\u03b1-Synuclein modulates tau spreading in mouse brains","volume":"218","author":"Bassil","year":"2021","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/bs.pbr.2022.01.014_bb0055","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jnnp-2020-325668","article-title":"Sex differences for phenotype in pathologically defined dementia with Lewy bodies","volume":"92","author":"Bayram","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/bs.pbr.2022.01.014_bb0060","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00401-008-0409-8","article-title":"Evaluation of alpha-synuclein immunohistochemical methods used by invited experts","volume":"116","author":"Beach","year":"2008","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1016\/bs.pbr.2022.01.014_bb0065","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00401-009-0538-8","article-title":"Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction","volume":"117","author":"Beach","year":"2009","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/bs.pbr.2022.01.014_bb0070","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3233\/JPD-160888","article-title":"Multicenter assessment of immunohistochemical methods for pathological alpha-synuclein in sigmoid colon of autopsied Parkinson's disease and control subjects","volume":"6","author":"Beach","year":"2016","journal-title":"J. Parkinsons Dis."},{"issue":"9","key":"10.1016\/bs.pbr.2022.01.014_bb0075","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/jnen\/nly056","article-title":"Immunohistochemical method and histopathology judging for the systemic synuclein sampling study (S4)","volume":"77","author":"Beach","year":"2018","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"6","key":"10.1016\/bs.pbr.2022.01.014_bb0080","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","article-title":"The function of \u03b1-synuclein","volume":"79","author":"Bendor","year":"2013","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/bs.pbr.2022.01.014_bb0085","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/mds.25929","article-title":"Extra-nigral pathological conditions are common in Parkinson's disease with freezing of gait: an in vivo positron emission tomography study","volume":"29","author":"Bohnen","year":"2014","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/bs.pbr.2022.01.014_bb0090","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/bs.pbr.2022.01.014_bb0095","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson's disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res."},{"issue":"8","key":"10.1016\/bs.pbr.2022.01.014_bb0100","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/01.WNL.0000158422.41380.82","article-title":"Cognitive status correlates with neuropathologic stage in Parkinson disease","volume":"64","author":"Braak","year":"2005","journal-title":"Neurology"},{"issue":"16","key":"10.1016\/bs.pbr.2022.01.014_bb0105","doi-asserted-by":"crossref","first-page":"e1821","DOI":"10.1212\/WNL.0000000000007315","article-title":"Progressive parkinsonism in older adults is related to the burden of mixed brain pathologies","volume":"92","author":"Buchman","year":"2019","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/bs.pbr.2022.01.014_bb0110","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/gerona\/glaa176","article-title":"Person-specific contributions of brain pathologies to progressive parkinsonism in older adults","volume":"76","author":"Buchman","year":"2021","journal-title":"J. Gerontol. A"},{"issue":"2","key":"10.1016\/bs.pbr.2022.01.014_bb0115","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/ene.13797","article-title":"Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease","volume":"26","author":"Chahine","year":"2019","journal-title":"Eur. J. Neurol."},{"issue":"9","key":"10.1016\/bs.pbr.2022.01.014_bb0120","doi-asserted-by":"crossref","first-page":"e1267","DOI":"10.1212\/WNL.0000000000010404","article-title":"In vivo distribution of \u03b1-synuclein in multiple tissues and biofluids in Parkinson disease","volume":"95","author":"Chahine","year":"2020","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/bs.pbr.2022.01.014_bb0125","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/jnnp.74.7.852","article-title":"Lewy body cortical involvement may not always predict dementia in Parkinson's disease","volume":"74","author":"Colosimo","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"15","key":"10.1016\/bs.pbr.2022.01.014_bb0130","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1002\/mds.22594","article-title":"Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease","volume":"24","author":"Compta","year":"2009","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/bs.pbr.2022.01.014_bb0135","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/brain\/awr031","article-title":"Lewy-and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?","volume":"134","author":"Compta","year":"2011","journal-title":"Brain"},{"issue":"8","key":"10.1016\/bs.pbr.2022.01.014_bb0140","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.parkreldis.2013.03.009","article-title":"Combined dementia-risk biomarkers in Parkinson's disease: a prospective longitudinal study","volume":"19","author":"Compta","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"issue":"2\u20133","key":"10.1016\/bs.pbr.2022.01.014_bb0145","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000354670","article-title":"The significance of \u03b1-synuclein, amyloid-\u03b2 and tau pathologies in Parkinson's disease progression and related dementia","volume":"13","author":"Compta","year":"2014","journal-title":"Neurodegener Dis"},{"key":"10.1016\/bs.pbr.2022.01.014_bb0150","series-title":"\u2018Cerebrospinal Fluid AD Biomarkers and Regional [18F]-Flortaucipir Uptake in Lewy Body Disorders (s10. 009)","author":"Coughlin","year":"2019"},{"issue":"2","key":"10.1016\/bs.pbr.2022.01.014_bb0155","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ana.25392","article-title":"Cognitive and pathological influences of tau pathology in Lewy body disorders","volume":"85","author":"Coughlin","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/bs.pbr.2022.01.014_bb0160","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.parkreldis.2019.03.023","article-title":"Most cases with Lewy pathology in a population-based cohort adhere to the Braak progression pattern but \u2018failure to fit\u2019 is highly dependent on staging system applied","volume":"64","author":"Coughlin","year":"2019","journal-title":"Parkinsonism Relat. Disord"},{"key":"10.1016\/bs.pbr.2022.01.014_bb0165","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neurobiolaging.2020.08.003","article-title":"Multimodal in vivo and post-mortem assessments of tau in Lewy body disorders","volume":"96","author":"Coughlin","year":"2020","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/bs.pbr.2022.01.014_bb0170","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00002093-200101000-00005","article-title":"Clinical and pathologic features of two groups of patients with dementia with Lewy bodies: effect of coexisting Alzheimer-type lesion load","volume":"15","author":"Del Ser","year":"2001","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"4","key":"10.1016\/bs.pbr.2022.01.014_bb0175","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00401-008-0345-7","article-title":"Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease","volume":"115","author":"Dickson","year":"2008","journal-title":"Acta Neuropathol."},{"issue":"10","key":"10.1016\/bs.pbr.2022.01.014_bb0180","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/mds.25952","article-title":"Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease","volume":"29","author":"Dijkstra","year":"2014","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/bs.pbr.2022.01.014_bb0185","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/ene.13939","article-title":"Abnormal \u03b1-synuclein deposits in skin nerves: intra- and inter-laboratory reproducibility","volume":"26","author":"Dobadio","year":"2019","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/bs.pbr.2022.01.014_bb0190","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00401-014-1284-0","article-title":"Cutaneous neuropathy in Parkinson's disease: a window into brain pathology","volume":"128","author":"Doppler","year":"2014","journal-title":"Acta Neuropathol."},{"issue":"16","key":"10.1016\/bs.pbr.2022.01.014_bb0195","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/mds.21844","article-title":"Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force","volume":"22","author":"Dubois","year":"2007","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/bs.pbr.2022.01.014_bb0200","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neurol.2015.09.012","article-title":"Epidemiology of Parkinson's disease","volume":"172","author":"Elbaz","year":"2016","journal-title":"Rev. Neurol."},{"issue":"7","key":"10.1016\/bs.pbr.2022.01.014_bb0205","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1212\/WNL.0000000000006926","article-title":"Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases","volume":"92","author":"Espay","year":"2019","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/bs.pbr.2022.01.014_bb0210","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jamaneurol.2015.0703","article-title":"New clinical subtypes of Parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes","volume":"72","author":"Fereshtehnejad","year":"2015","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/bs.pbr.2022.01.014_bb0215","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jalz.2017.09.014","article-title":"The limbic and neocortical contribution of \u03b1-synuclein, tau, and amyloid \u03b2 to disease duration in dementia with Lewy bodies","volume":"14","author":"Ferman","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"6","key":"10.1016\/bs.pbr.2022.01.014_bb0220","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/brain\/awm305","article-title":"Argyrophilic grain disease","volume":"131","author":"Ferrer","year":"2008","journal-title":"Brain"},{"issue":"SUPPL SEPT","key":"10.1016\/bs.pbr.2022.01.014_bb0225","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.parkreldis.2007.06.003","article-title":"The economic impact of Parkinson's disease","volume":"13","author":"Findley","year":"2007","journal-title":"Parkinsonism Relat. Disord."},{"issue":"15","key":"10.1016\/bs.pbr.2022.01.014_bb0230","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1002\/mds.23393","article-title":"Amyloid imaging of Lewy body-associated disorders","volume":"25","author":"Foster","year":"2010","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/bs.pbr.2022.01.014_bb0235","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1750-3639.2008.00169.x","article-title":"Clinicopathological outline of dementia with Lewy bodies applying the revised criteria: the Hisayama study","volume":"18","author":"Fujimi","year":"2008","journal-title":"Brain Pathol."},{"issue":"2","key":"10.1016\/bs.pbr.2022.01.014_bb0240","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archneur.56.2.203","article-title":"Neurofibrillary pathology in Alzheimer disease with Lewy bodies: two subgroups","volume":"56","author":"Gearing","year":"1999","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/bs.pbr.2022.01.014_bb0245","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3233\/JPD-171088","article-title":"Cutaneous alpha-synuclein from paraffin embedded autopsy specimens in Parkinson's disease","volume":"7","author":"Gibbons","year":"2017","journal-title":"J. Parkinsons Dis."},{"issue":"12","key":"10.1016\/bs.pbr.2022.01.014_bb0250","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1212\/01.wnl.0000326146.60732.d6","article-title":"Imaging amyloid deposition in Lewy body diseases","volume":"71","author":"Gomperts","year":"2008","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/bs.pbr.2022.01.014_bb0255","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1001\/jamaneurol.2016.3338","article-title":"Tau positron emission tomographic imaging in the Lewy body diseases","volume":"73","author":"Gomperts","year":"2016","journal-title":"JAMA Neurol."},{"issue":"8","key":"10.1016\/bs.pbr.2022.01.014_bb0260","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/j.1468-1331.2012.03682.x","article-title":"The impact of silent vascular brain burden in cognitive impairment in Parkinson's disease","volume":"19","author":"Gonz\u00e1lez-Redondo","year":"2012","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/bs.pbr.2022.01.014_bb0265","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neurobiolaging.2008.03.015","article-title":"A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death","volume":"31","author":"Greffard","year":"2010","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/bs.pbr.2022.01.014_bb0270","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cell.2013.05.057","article-title":"Distinct \u03b1-synuclein strains differentially promote tau inclusions in neurons","volume":"154","author":"Guo","year":"2013","journal-title":"Cell"},{"issue":"11","key":"10.1016\/bs.pbr.2022.01.014_bb0275","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/archneurol.2012.1654","article-title":"Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and\/or parkinsonian disorders","volume":"69","author":"Hall","year":"2012","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/bs.pbr.2022.01.014_bb0280","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1212\/WNL.0000000000001098","article-title":"CSF biomarkers and clinical progression of Parkinson disease","volume":"84","author":"Hall","year":"2015","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/bs.pbr.2022.01.014_bb0285","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00401-008-0344-8","article-title":"The progression of pathology in longitudinally followed patients with Parkinson's disease","volume":"115","author":"Halliday","year":"2008","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/bs.pbr.2022.01.014_bb0290","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00702-011-0641-6","article-title":"Striatal beta-amyloid in dementia with Lewy bodies but not Parkinson's disease","volume":"118","author":"Halliday","year":"2011","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"2","key":"10.1016\/bs.pbr.2022.01.014_bb0295","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/brain\/awf033","article-title":"Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe","volume":"125","author":"Harding","year":"2002","journal-title":"Brain"},{"issue":"6","key":"10.1016\/bs.pbr.2022.01.014_bb0300","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1600-0404.2005.00389.x","article-title":"The influence of cerebrovascular risk factors on incident dementia in patients with Parkinson's disease","volume":"112","author":"Haugarvoll","year":"2005","journal-title":"Acta Neurol. Scand."},{"issue":"6","key":"10.1016\/bs.pbr.2022.01.014_bb0305","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mds.21956","article-title":"The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years","volume":"23","author":"Hely","year":"2008","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/bs.pbr.2022.01.014_bb0310","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1076\/jhin.11.1.19.9106","article-title":"Friedrich Heinrich Lewy (1885\u20131950) and his work","volume":"11","author":"Holdorff","year":"2002","journal-title":"J. Hist. Neurosci."},{"issue":"Pt 3","key":"10.1016\/bs.pbr.2022.01.014_bb0315","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/brain\/awq008","article-title":"DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease","volume":"133","author":"Hong","year":"2010","journal-title":"Brain"},{"issue":"10","key":"10.1016\/bs.pbr.2022.01.014_bb0320","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.parkreldis.2013.05.010","article-title":"Neuropathology of dementia in a large cohort of patients with Parkinson's disease","volume":"19","author":"Horvath","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"issue":"4","key":"10.1016\/bs.pbr.2022.01.014_bb0325","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/bpa.12182","article-title":"Regional multiple pathology scores are associated with cognitive decline in L ewy body dementias","volume":"25","author":"Howlett","year":"2015","journal-title":"Brain Pathol."},{"issue":"10","key":"10.1016\/bs.pbr.2022.01.014_bb0330","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/WNL.54.10.1916","article-title":"Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease","volume":"54","author":"Hurtig","year":"2000","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/bs.pbr.2022.01.014_bb0335","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1474-4422(20)30449-X","article-title":"Detection of \u03b1-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study","volume":"20","author":"Iranzo","year":"2021","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/bs.pbr.2022.01.014_bb0340","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/ana.23659","article-title":"Neuropathologic substrates of Parkinson disease dementia","volume":"72","author":"Irwin","year":"2012","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/bs.pbr.2022.01.014_bb0345","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn3549","article-title":"Parkinson's disease dementia: convergence of [alpha]-synuclein, tau and amyloid-[beta] pathologies","volume":"14","author":"Irwin","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/bs.pbr.2022.01.014_bb0350","series-title":"Annals of Neurology","first-page":"S56","article-title":"Antemortem CSF tau and a beta biomarkers are predictive of postmortem Alzheimer's disease pathology in autopsy-confirmed Lewy body disease","author":"Irwin","year":"2017"},{"issue":"1","key":"10.1016\/bs.pbr.2022.01.014_bb0355","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","article-title":"Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis","volume":"16","author":"Irwin","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/bs.pbr.2022.01.014_bb0360","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000005166","article-title":"CSF tau and amyloid-beta predict cerebral synucleinopathy in autopsied Lewy body disorders","author":"Irwin","year":"2018","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/bs.pbr.2022.01.014_bb0365","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ana.25811","article-title":"Evolution of Alzheimer's disease cerebrospinal fluid biomarkers in early Parkinson's disease","volume":"88","author":"Irwin","year":"2020","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/bs.pbr.2022.01.014_bb0370","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"3","key":"10.1016\/bs.pbr.2022.01.014_bb0375","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/mds.870110306","article-title":"A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type a in essential hand tremor","volume":"11","author":"Jankovic","year":"1996","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/bs.pbr.2022.01.014_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-008-0406-y","article-title":"A critical reappraisal of current staging of Lewy-related pathology in human brain","volume":"116","author":"Jellinger","year":"2008","journal-title":"Acta Neuropathol."},{"issue":"3\u20134","key":"10.1016\/bs.pbr.2022.01.014_bb0385","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000113679","article-title":"Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia","volume":"5","author":"Jellinger","year":"2008","journal-title":"Neurodegenerative Dis."},{"issue":"3","key":"10.1016\/bs.pbr.2022.01.014_bb0390","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00401-006-0088-2","article-title":"Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies?","volume":"112","author":"Jellinger","year":"2006","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/bs.pbr.2022.01.014_bb0395","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12916-018-1016-8","article-title":"Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?","volume":"16","author":"Jellinger","year":"2018","journal-title":"BMC Med."},{"issue":"3","key":"10.1016\/bs.pbr.2022.01.014_bb0400","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s007020200027","article-title":"Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease","volume":"109","author":"Jellinger","year":"2002","journal-title":"J. Neural Transm."},{"issue":"2","key":"10.1016\/bs.pbr.2022.01.014_bb0405","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/NEN.0b013e31816362aa","article-title":"Striatal beta-amyloid deposition in Parkinson disease with dementia","volume":"67","author":"Kalaitzakis","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"10","key":"10.1016\/bs.pbr.2022.01.014_bb0410","first-page":"1277","article-title":"Association of cerebrospinal fluid beta-amyloid 1-42, T-tau, P-tau181, and alpha-synuclein levels with clinical features of drug-naive patients with early Parkinson disease","volume":"70","author":"Kang","year":"2013","journal-title":"JAMA Neurol."},{"issue":"6","key":"10.1016\/bs.pbr.2022.01.014_bb0415","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00401-016-1552-2","article-title":"CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's progression markers initiative study","volume":"131","author":"Kang","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/bs.pbr.2022.01.014_bb0420","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/mds.27646","article-title":"Comparative study of cerebrospinal fluid \u03b1-synuclein seeding aggregation assays for diagnosis of Parkinson's disease","volume":"34","author":"Kang","year":"2019","journal-title":"Mov. Disord."},{"issue":"22","key":"10.1016\/bs.pbr.2022.01.014_bb0425","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1212\/WNL.0000000000003371","article-title":"Hippocampal volumes predict risk of dementia with Lewy bodies in mild cognitive impairment","volume":"87","author":"Kantarci","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/bs.pbr.2022.01.014_bb0430","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ana.24825","article-title":"AV-1451 tau and \u03b2-amyloid positron emission tomography imaging in dementia with Lewy bodies","volume":"81","author":"Kantarci","year":"2017","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/bs.pbr.2022.01.014_bb0435","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/brain\/awq059","article-title":"Relationships between age and late progression of Parkinson's disease: a clinico-pathological study","volume":"133","author":"Kempster","year":"2010","journal-title":"Brain"},{"issue":"4","key":"10.1016\/bs.pbr.2022.01.014_bb0440","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","article-title":"Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson's disease","volume":"103","author":"Kim","year":"2019","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/bs.pbr.2022.01.014_bb0445","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1001\/archneurol.2012.1608","article-title":"Pathologic accumulation of alpha-synuclein and Abeta in Parkinson disease patients with dementia","volume":"69","author":"Kotzbauer","year":"2012","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/bs.pbr.2022.01.014_bb0450","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00401-003-0705-2","article-title":"Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease","volume":"106","author":"K\u00f6vari","year":"2003","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1016\/bs.pbr.2022.01.014_bb0455","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1523\/JNEUROSCI.4564-06.2007","article-title":"Presynaptic \u03b1-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies","volume":"27","author":"Kramer","year":"2007","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/bs.pbr.2022.01.014_bb0460","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00401-018-1947-3","article-title":"Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease","volume":"137","author":"Kraus","year":"2019","journal-title":"Acta Neuropathol."},{"issue":"12","key":"10.1016\/bs.pbr.2022.01.014_bb0465","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1212\/01.WNL.0000165987.89198.65","article-title":"Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both","volume":"64","author":"Kraybill","year":"2005","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/bs.pbr.2022.01.014_bb0470","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bbrc.2008.05.045","article-title":"Clearance and deposition of extracellular alpha-synuclein aggregates in microglia","volume":"372","author":"Lee","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/bs.pbr.2022.01.014_bb0475","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/mds.27252","article-title":"Distinct patterns of amyloid-dependent tau accumulation in Lewy body diseases","volume":"33","author":"Lee","year":"2018","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/bs.pbr.2022.01.014_bb0480","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1212\/01.wnl.0000256715.13907.d3","article-title":"DLB and PDD boundary issues diagnosis, treatment, molecular pathology, and biomarkers","volume":"68","author":"Lippa","year":"2007","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/bs.pbr.2022.01.014_bb0485","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/mds.23823","article-title":"MDS task force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI","volume":"26","author":"Litvan","year":"2011","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/bs.pbr.2022.01.014_bb0490","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.parkreldis.2014.12.027","article-title":"CSF tau and tau\/Abeta42 predict cognitive decline in Parkinson's disease","volume":"21","author":"Liu","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"10.1016\/bs.pbr.2022.01.014_bb0495","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archneur.59.1.43","article-title":"Research evaluation and prospective diagnosis of dementia with Lewy bodies","volume":"59","author":"Lopez","year":"2002","journal-title":"Arch. Neurol."},{"issue":"6109","key":"10.1016\/bs.pbr.2022.01.014_bb0500","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"issue":"5","key":"10.1016\/bs.pbr.2022.01.014_bb0505","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/jon.12230","article-title":"White matter hyperintensities and mild cognitive impairment in Parkinson's disease","volume":"25","author":"Mak","year":"2015","journal-title":"J. Neuroimaging"},{"issue":"10","key":"10.1016\/bs.pbr.2022.01.014_bb0510","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/mds.26698","article-title":"Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease","volume":"31","author":"Malek","year":"2016","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/bs.pbr.2022.01.014_bb0515","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/mds.27907","article-title":"\u03b1-Synuclein real-time quaking-induced conversion in the submandibular glands of Parkinson's disease patients","volume":"35","author":"Manne","year":"2020","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/bs.pbr.2022.01.014_bb0520","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/NEN.0b013e3181ac10a7","article-title":"Lewy body pathology in Normal elderly subjects","volume":"68","author":"Markesbery","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/bs.pbr.2022.01.014_bb0525","first-page":"1","article-title":"Prevalence of Parkinson's disease across North America","volume":"4","author":"Marras","year":"2018","journal-title":"NPJ Parkinson's Dis."},{"issue":"2","key":"10.1016\/bs.pbr.2022.01.014_bb0530","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00401-004-0869-4","article-title":"Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease","volume":"108","author":"Marui","year":"2004","journal-title":"Acta Neuropathol."},{"issue":"5\u20136","key":"10.1016\/bs.pbr.2022.01.014_bb0535","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000464322","article-title":"Extremely low prevalence of amyloid positron emission tomography positivity in Parkinson's disease without dementia","volume":"77","author":"Mashima","year":"2017","journal-title":"Eur. Neurol."},{"issue":"11","key":"10.1016\/bs.pbr.2022.01.014_bb0540","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/jamaneurol.2014.1455","article-title":"APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease","volume":"71","author":"Mata","year":"2014","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/bs.pbr.2022.01.014_bb0545","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/mds.26359","article-title":"GBA variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease","volume":"31","author":"Mata","year":"2016","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/bs.pbr.2022.01.014_bb0550","doi-asserted-by":"crossref","first-page":"6","DOI":"10.17925\/ENR.2013.08.01.6","article-title":"Health economics and cost of illness in parkinson's disease","volume":"8","author":"Mateus","year":"2013","journal-title":"Eur. Neurol. Rev."},{"issue":"12","key":"10.1016\/bs.pbr.2022.01.014_bb0555","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/bs.pbr.2022.01.014_bb0560","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/acn3.669","article-title":"Cervical skin denervation associates with alpha-synuclein aggregates in Parkinson disease","volume":"5","author":"Melli","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"10","key":"10.1016\/bs.pbr.2022.01.014_bb0565","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/01.WNL.0000065889.42856.F2","article-title":"Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies","volume":"60","author":"Merdes","year":"2003","journal-title":"Neurology"},{"issue":"24","key":"10.1016\/bs.pbr.2022.01.014_bb0570","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1212\/WNL.0b013e318278fe32","article-title":"Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease","volume":"79","author":"Milber","year":"2012","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/bs.pbr.2022.01.014_bb0575","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000094871","article-title":"Beta-amlyoid 1\u201342 and tau-protein in cerebrospinal fluid of patients with Parkinson's disease dementia","volume":"22","author":"Mollenhauer","year":"2006","journal-title":"Dement. Geriatr. Cogn. Disord."},{"issue":"2","key":"10.1016\/bs.pbr.2022.01.014_bb0580","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1212\/WNL.0000000000002651","article-title":"Monitoring of 30 marker candidates in early Parkinson disease as progression markers","volume":"87","author":"Mollenhauer","year":"2016","journal-title":"Neurology"},{"issue":"15","key":"10.1016\/bs.pbr.2022.01.014_bb0585","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1002\/mds.23287","article-title":"CSF A\u03b242 and tau in Parkinson's disease with cognitive impairment","volume":"25","author":"Montine","year":"2010","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/bs.pbr.2022.01.014_bb0590","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/mds.25213","article-title":"\u03b2-Amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia","volume":"28","author":"M\u00fcller","year":"2013","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/bs.pbr.2022.01.014_bb0595","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1212\/01.wnl.0000180516.69442.95","article-title":"Cognitive profile of patients with newly diagnosed Parkinson disease","volume":"65","author":"Muslimovi\u0107","year":"2005","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/bs.pbr.2022.01.014_bb0600","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00401-007-0261-2","article-title":"Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases","volume":"114","author":"Nakashima-Yasuda","year":"2007","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/bs.pbr.2022.01.014_bb0605","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mds.20663","article-title":"Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia","volume":"21","author":"Pankratz","year":"2006","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/bs.pbr.2022.01.014_bb0610","first-page":"353","article-title":"Is ischemic cerebrovascular disease a risk factor for dementia in patients with Parkinson's disease?","volume":"113","author":"Papapetropoulos","year":"2006","journal-title":"Acta Neurol. Scand."},{"issue":"4","key":"10.1016\/bs.pbr.2022.01.014_bb0615","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1440-1789.2005.00644.x","article-title":"Widespread and abundant alpha-synuclein pathology in a neurologically unimpaired subject","volume":"25","author":"Parkkinen","year":"2005","journal-title":"Neuropathology"},{"issue":"1","key":"10.1016\/bs.pbr.2022.01.014_bb0620","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ana.20321","article-title":"\u03b1-Synuclein pathology does not predict extrapyramidal symptoms or dementia","volume":"57","author":"Parkkinen","year":"2005","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/bs.pbr.2022.01.014_bb0625","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00401-008-0346-6","article-title":"Applicability of current staging\/categorization of alpha-synuclein pathology and their clinical relevance","volume":"115","author":"Parkkinen","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/bs.pbr.2022.01.014_bb0630","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fnagi.2014.00053","article-title":"Differential role of CSF alpha-synuclein species, tau, and Abeta42 in Parkinson's disease","volume":"6","author":"Parnetti","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/bs.pbr.2022.01.014_bb0635","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.parkreldis.2016.07.008","article-title":"Phenotypic differences based on staging of Alzheimer's neuropathology in autopsy-confirmed dementia with Lewy bodies","volume":"31","author":"Peavy","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"issue":"7706","key":"10.1016\/bs.pbr.2022.01.014_bb0640","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41586-018-0104-4","article-title":"Cellular milieu imparts distinct pathological \u03b1-synuclein strains in \u03b1-synucleinopathies","volume":"557","author":"Peng","year":"2018","journal-title":"Nature"},{"issue":"11","key":"10.1016\/bs.pbr.2022.01.014_bb0645","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1212\/WNL.0b013e3182698d4a","article-title":"A\u03b2-amyloid deposition in patients with Parkinson disease at risk for development of dementia","volume":"79","author":"Petrou","year":"2012","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/bs.pbr.2022.01.014_bb0650","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3233\/JAD-150610","article-title":"Vascular risk factors and cognition in Parkinson's disease","volume":"51","author":"Pilotto","year":"2016","journal-title":"J. Alzheimers Dis."},{"issue":"12","key":"10.1016\/bs.pbr.2022.01.014_bb0655","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/bs.pbr.2022.01.014_bb0660","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.parkreldis.2008.02.007","article-title":"Vascular pathology in patients with idiopathic Parkinson's disease","volume":"15","author":"Rektor","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"issue":"6","key":"10.1016\/bs.pbr.2022.01.014_bb0665","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1586\/14737167.2015.1103184","article-title":"Estimating the direct and indirect costs associated with Parkinson's disease","volume":"15","author":"Rodr\u00edguez-Bl\u00e1zquez","year":"2015","journal-title":"Exp. Rev PharmacoeconOutcomes Res."},{"issue":"4","key":"10.1016\/bs.pbr.2022.01.014_bb0670","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ana.20226","article-title":"Parkinsonian signs and substantia nigra neuron density in decendents elders without PD","volume":"56","author":"Ross","year":"2004","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/bs.pbr.2022.01.014_bb0675","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/nan.12294","article-title":"Cortical Lewy bodies and A\u03b2 burden are associated with prevalence and timing of dementia in Lewy body diseases","volume":"42","author":"Ruffmann","year":"2016","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"1","key":"10.1016\/bs.pbr.2022.01.014_bb0680","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.parkreldis.2009.07.012","article-title":"Vascular risk factors do not contribute to motor and cognitive impairment in Parkinson's disease","volume":"16","author":"Slawek","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"issue":"3","key":"10.1016\/bs.pbr.2022.01.014_bb0685","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/WAD.0b013e31819c5ef4","article-title":"Parkinson disease with dementia: comparing patients with and without Alzheimer pathology","volume":"23","author":"Sabbagh","year":"2009","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/bs.pbr.2022.01.014_bb0690","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-1-4939-8820-4_2","article-title":"Ultrasensitive RT-QuIC seed amplification assays for disease-associated tau, alpha-synuclein, and prion aggregates","volume":"1873","author":"Saijo","year":"2019","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"10.1016\/bs.pbr.2022.01.014_bb0695","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00401-010-0711-0","article-title":"The synaptic pathology of \u03b1-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia","volume":"120","author":"Schulz-Schaeffer","year":"2010","journal-title":"Acta Neuropathol."},{"issue":"Pt 11","key":"10.1016\/bs.pbr.2022.01.014_bb0700","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1093\/brain\/awp234","article-title":"A clinico-pathological study of subtypes in Parkinson's disease","volume":"132","author":"Selikhova","year":"2009","journal-title":"Brain"},{"issue":"1","key":"10.1016\/bs.pbr.2022.01.014_bb0705","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/mds.26369","article-title":"Striatal and cortical \u03b2-Amyloidopathy and cognition in Parkinson's disease","volume":"31","author":"Shah","year":"2016","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/bs.pbr.2022.01.014_bb0710","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jamaneurol.2016.4547","article-title":"Development of a biochemical diagnosis of Parkinson disease by detection of \u03b1-synuclein misfolded aggregates in cerebrospinal fluid","volume":"74","author":"Shahnawaz","year":"2017","journal-title":"JAMA Neurol."},{"issue":"7794","key":"10.1016\/bs.pbr.2022.01.014_bb0715","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","article-title":"Discriminating \u03b1-synuclein strains in Parkinson's disease and multiple system atrophy","volume":"578","author":"Shahnawaz","year":"2020","journal-title":"Nature"},{"issue":"12","key":"10.1016\/bs.pbr.2022.01.014_bb0720","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1212\/WNL.0b013e3181f39a78","article-title":"CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease","volume":"75","author":"Siderowf","year":"2010","journal-title":"Neurology"},{"issue":"17","key":"10.1016\/bs.pbr.2022.01.014_bb0725","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/bs.pbr.2022.01.014_bb0730","first-page":"1234","article-title":"Neuropathology of dementia in patients with Parkinson's disease: a systematic review of autopsy studies","volume":"90","author":"Smith","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/bs.pbr.2022.01.014_bb0735","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1038\/s41598-018-23041-x","article-title":"18F-AV-1451 in Parkinson's disease with and without dementia and in dementia with Lewy bodies","volume":"8","author":"Smith","year":"2018","journal-title":"Sci. Rep."},{"issue":"6645","key":"10.1016\/bs.pbr.2022.01.014_bb0740","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"issue":"4","key":"10.1016\/bs.pbr.2022.01.014_bb0745","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.ajpath.2013.12.007","article-title":"Cerebrospinal fluid alpha-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort","volume":"184","author":"Stewart","year":"2014","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/bs.pbr.2022.01.014_bb0750","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrn.2016.178","article-title":"Selective neuronal vulnerability in Parkinson disease","volume":"18","author":"Surmeier","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/bs.pbr.2022.01.014_bb0755","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/archneurol.2008.596","article-title":"Cerebrospinal fluid beta-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain","volume":"66","author":"Tapiola","year":"2009","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/bs.pbr.2022.01.014_bb0760","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00401-012-0983-7","article-title":"CSF biomarkers cutoffs: the importance of coincident neuropathological diseases","volume":"124","author":"Toledo","year":"2012","journal-title":"Acta Neuropathol."},{"issue":"19","key":"10.1016\/bs.pbr.2022.01.014_bb0765","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1212\/WNL.0b013e3182735e9a","article-title":"GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology","volume":"79","author":"Tsuang","year":"2012","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/bs.pbr.2022.01.014_bb0770","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jamaneurol.2013.600","article-title":"APOE \u03f54 increases risk for dementia in pure synucleinopathies","volume":"70","author":"Tsuang","year":"2013","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/bs.pbr.2022.01.014_bb0775","first-page":"70001","article-title":"Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology","volume":"13","author":"Tsuboi","year":"2007","journal-title":"Parkinsonism Relat. Disord."},{"issue":"28","key":"10.1016\/bs.pbr.2022.01.014_bb0780","doi-asserted-by":"crossref","first-page":"9364","DOI":"10.1523\/JNEUROSCI.4787-13.2014","article-title":"Synucleins regulate the kinetics of synaptic vesicle endocytosis","volume":"34","author":"Vargas","year":"2014","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/bs.pbr.2022.01.014_bb0785","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.2967\/jnumed.111.089730","article-title":"Amyloid imaging with 18F-florbetaben in Alzheimer disease and other dementias","volume":"52","author":"Villemagne","year":"2011","journal-title":"J. Nucl. Med."},{"issue":"4","key":"10.1016\/bs.pbr.2022.01.014_bb0790","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s00401-003-0750-x","article-title":"Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study","volume":"106","author":"Wakisaka","year":"2003","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/bs.pbr.2022.01.014_bb0795","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00401-015-1406-3","article-title":"Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes","volume":"129","author":"Walker","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/bs.pbr.2022.01.014_bb0800","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2013-305277","article-title":"The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort","author":"Williams-Gray","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"10","key":"10.1016\/bs.pbr.2022.01.014_bb0805","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In vivo demonstration that \u03b1-synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/bs.pbr.2022.01.014_bb0810","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1212\/WNL.0000000000000066","article-title":"Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study","volume":"82","author":"Yarnall","year":"2014","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/bs.pbr.2022.01.014_bb0815","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13195-015-0101-x","article-title":"Alpha-synucleinopathy and neuropsychological symptoms in a population-based cohort of the elderly","volume":"7","author":"Zaccai","year":"2015","journal-title":"Alzheimer's Res. Ther."},{"issue":"09\/08","key":"10.1016\/bs.pbr.2022.01.014_bb0820","first-page":"4","article-title":"Network structure of brain atrophy in de novo Parkinson's disease","volume":"2015","author":"Zeighami","year":"2015","journal-title":"Elife"},{"issue":"5","key":"10.1016\/bs.pbr.2022.01.014_bb0825","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00401-013-1121-x","article-title":"Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease","volume":"126","author":"Zhang","year":"2013","journal-title":"Acta Neuropathol."}],"container-title":["Progress in Brain Research","Cognition in Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612322000140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612322000140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T13:09:09Z","timestamp":1753448949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0079612322000140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9780323901642"],"references-count":164,"URL":"https:\/\/doi.org\/10.1016\/bs.pbr.2022.01.014","relation":{},"ISSN":["0079-6123"],"issn-type":[{"value":"0079-6123","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}